<DOC>
	<DOCNO>NCT00282997</DOCNO>
	<brief_summary>To evaluate safety pregabalin patient fibromyalgia .</brief_summary>
	<brief_title>A Safety Study Of Pregabalin In Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must meet ACR criterion fibromyalgia ( ie , widespread pain present least 3 month , pain least 11 18 specific tender point site . Patients must complete doubleblind study . Patients experience serious adverse event previous fibromyalgia study , determine related study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>